Comparable Efficacy of Epoetin Alfa for Anemic Cancer Patients Receiving Platinum- and Nonplatinum-Based Chemotherapy: A Retrospective Subanalysis of Two Large, Community-Based Trials

Standard of care for cancer-related anemia: Improving hemoglobin levels and quality of life

Cortesi, Enrico
P., Gascon
David, Henry
Timothy, Littlewood
Robert, Milroy
Paolo, Pronzato
Uwe, Reinhardt
Daniel, Shasha
Nicholas, Thatcher
Peter, Wilkinson

January 2005

The introduction of recombinant human erythropoietin (rHuEPO) has proven to be a major advance in th...

Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study

Masahiro Tsuboi
Kohji Ezaki
Kensei Tobinai
Yasuo Ohashi
Nagahiro Saijo

January 2008

Objective: The efficacy and safety of weekly administration of epoetin beta (EPO) for chemotherapy-i...

Strategies for the Use of Epoetin Alfa in Breast Cancer Patients

Lucia Del Mastro
Marco Venturini
Guest On A
Lucia Del Mastro
B Marco Venturinib

January 2014

The online version of this article, along with updated information and services, is located o

Epoetin Alfa Treatment in Anemic Cancer Patients: Results of a Prospective, Increased Hemoglobin Levels and Improved Quality-of-Life Assessments During doi: 10.1634/theoncologist.10-3-225

Uwe Reinhardt
Augustinos Tulusan
Ralf Angermund
Harald Lutz
Multicenter German Trial

August 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: Results of a european, multicenter, randomized, controlled trial

Pronzato, Paolo
Cortesi, Enrico
Rijt, Carin
Bols, Alain
Moreno-Nogueira, José
Oliveira, C.F.
Barrett-Lee, Peter
Ostler, Peter
Rosso, Ricardo

October 2010

textabstractPurpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in...

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

José A. Moreno-nogueira
E Carlos Freire De Oliveira
F Peter Barrett-lee
G Peter J. Ostler

October 2016

The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial.

P. Pronzato
Enrico Cortesi
C.C. Van Der Rijt
A. Bols
J.A. Moreno-Nogueira
C.F. De Oliveira
P. Barrett-Lee
P.J. Ostler
R. Rosso

January 2010

Purpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in patients wi...

A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study

Santini D
Vincenzi B
La Cesa A
Virzi V
Navajas F
Malafarina V
Dicuonzo G
Cassandro R
Esposito V
Montesarchio V
Groeger AM
Tonini G

January 2005

Background: Chronic anemia is a well-recognized complication of both cancer and cytotoxic treatments...

SPECIAL ARTICLE Use of Epoet in in Pat ients With Cancer: Ev idence-Based Cl inica l Pract ice Guidel ines of the American Socie ty of Cl in ica l Oncology and the American Socie ty of Hematology

J. Douglas Rizzo
Alan E. Lichtin
Steven H. Woolf
Jerome Seidenfeld
Charles L. Bennett
David Cella
Benjamin Djulbegovic
Matthew J. Goode
Ann A. Jakubowski
Stephanie J. Lee
Carole B. Miller
Mark U. Rarick
David H. Regan
George P. Browman
Michael S. Gordon

October 2016

Abstract: Anemia resulting from cancer, or its treat-ment, is an important clinical problem increasi...

Epoetin alfa improves quality of life in patients with cancer

Jones, Michael
Schenkel, Brad
Just, Just
Fallowfield, Lesley

October 2004

BACKGROUND: Anemia in patients with cancer causes fatigue, weakness, and impaired concentration,...

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

R. Laufman
David H. Henry
Naomi V. Dahl
Michael Auerbach
Simon Tchekmedyian
David H. Henry
A Naomi V. Dahl
B Michael Auerbach
C Simon Tchekmedyian
Leslie R. Laufmane

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia

Iain RJ Macpherson
Colin R Lindsay
Nicholas S Reed

March 2009

Iain RJ Macpherson, Colin R Lindsay, Nicholas S ReedBeatson West of Scotland Cancer Centre, Glasgow,...

Antianemic Effect of Once Weekly Regimen of Epoetin Alfa 40,000 Units in Anemic Cancer Patients Receiving Chemotherapy

Narin Voravud Md
Virote Sriuranpong Md
Harit Suwanrusme Md

January 2015

Background: Anemia is a common problem in the cancer population that is the result of clinical conse...

REVIEW Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials

Jerome Seidenfeld
Margaret Piper
Carole Flamm
Victor Hasselblad
James O
Charles L. Bennett
Michael S. Gordon
Allan E. Lichtin
James L. Wade Iii
Steven Woolf
Naomi Aronson

December 2014

Epoetin treatment offers an attractive but costly alternative to red blood cell transfusion for mana...

rHuEPO and treatment outcomes: the clinical experience

Hudis, C
Van Belle, Simon
Chang, J.
Muenstedt, K

January 2004

Increasingly, anemia is being recognized as a negative prognostic and predictive factor for patients...

Standard of care for cancer-related anemia: Improving hemoglobin levels and quality of life

Cortesi, Enrico
P., Gascon
David, Henry
Timothy, Littlewood
Robert, Milroy
Paolo, Pronzato
Uwe, Reinhardt
Daniel, Shasha
Nicholas, Thatcher
Peter, Wilkinson

January 2005

The introduction of recombinant human erythropoietin (rHuEPO) has proven to be a major advance in th...

Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study

Masahiro Tsuboi
Kohji Ezaki
Kensei Tobinai
Yasuo Ohashi
Nagahiro Saijo

January 2008

Objective: The efficacy and safety of weekly administration of epoetin beta (EPO) for chemotherapy-i...

Strategies for the Use of Epoetin Alfa in Breast Cancer Patients

Lucia Del Mastro
Marco Venturini
Guest On A
Lucia Del Mastro
B Marco Venturinib

January 2014

The online version of this article, along with updated information and services, is located o

Epoetin Alfa Treatment in Anemic Cancer Patients: Results of a Prospective, Increased Hemoglobin Levels and Improved Quality-of-Life Assessments During doi: 10.1634/theoncologist.10-3-225

Uwe Reinhardt
Augustinos Tulusan
Ralf Angermund
Harald Lutz
Multicenter German Trial

August 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: Results of a european, multicenter, randomized, controlled trial

Pronzato, Paolo
Cortesi, Enrico
Rijt, Carin
Bols, Alain
Moreno-Nogueira, José
Oliveira, C.F.
Barrett-Lee, Peter
Ostler, Peter
Rosso, Ricardo

October 2010

textabstractPurpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in...

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

José A. Moreno-nogueira
E Carlos Freire De Oliveira
F Peter Barrett-lee
G Peter J. Ostler

October 2016

The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial.

P. Pronzato
Enrico Cortesi
C.C. Van Der Rijt
A. Bols
J.A. Moreno-Nogueira
C.F. De Oliveira
P. Barrett-Lee
P.J. Ostler
R. Rosso

January 2010

Purpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in patients wi...

A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study

Santini D
Vincenzi B
La Cesa A
Virzi V
Navajas F
Malafarina V
Dicuonzo G
Cassandro R
Esposito V
Montesarchio V
Groeger AM
Tonini G

January 2005

Background: Chronic anemia is a well-recognized complication of both cancer and cytotoxic treatments...

SPECIAL ARTICLE Use of Epoet in in Pat ients With Cancer: Ev idence-Based Cl inica l Pract ice Guidel ines of the American Socie ty of Cl in ica l Oncology and the American Socie ty of Hematology

J. Douglas Rizzo
Alan E. Lichtin
Steven H. Woolf
Jerome Seidenfeld
Charles L. Bennett
David Cella
Benjamin Djulbegovic
Matthew J. Goode
Ann A. Jakubowski
Stephanie J. Lee
Carole B. Miller
Mark U. Rarick
David H. Regan
George P. Browman
Michael S. Gordon

October 2016

Abstract: Anemia resulting from cancer, or its treat-ment, is an important clinical problem increasi...

Epoetin alfa improves quality of life in patients with cancer

Jones, Michael
Schenkel, Brad
Just, Just
Fallowfield, Lesley

October 2004

BACKGROUND: Anemia in patients with cancer causes fatigue, weakness, and impaired concentration,...

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

R. Laufman
David H. Henry
Naomi V. Dahl
Michael Auerbach
Simon Tchekmedyian
David H. Henry
A Naomi V. Dahl
B Michael Auerbach
C Simon Tchekmedyian
Leslie R. Laufmane

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia

Iain RJ Macpherson
Colin R Lindsay
Nicholas S Reed

March 2009

Iain RJ Macpherson, Colin R Lindsay, Nicholas S ReedBeatson West of Scotland Cancer Centre, Glasgow,...

Antianemic Effect of Once Weekly Regimen of Epoetin Alfa 40,000 Units in Anemic Cancer Patients Receiving Chemotherapy

Narin Voravud Md
Virote Sriuranpong Md
Harit Suwanrusme Md

January 2015

Background: Anemia is a common problem in the cancer population that is the result of clinical conse...

REVIEW Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials

Jerome Seidenfeld
Margaret Piper
Carole Flamm
Victor Hasselblad
James O
Charles L. Bennett
Michael S. Gordon
Allan E. Lichtin
James L. Wade Iii
Steven Woolf
Naomi Aronson

December 2014

Epoetin treatment offers an attractive but costly alternative to red blood cell transfusion for mana...

rHuEPO and treatment outcomes: the clinical experience

Hudis, C
Van Belle, Simon
Chang, J.
Muenstedt, K

January 2004

Increasingly, anemia is being recognized as a negative prognostic and predictive factor for patients...

Standard of care for cancer-related anemia: Improving hemoglobin levels and quality of life

Cortesi, Enrico
P., Gascon
David, Henry
Timothy, Littlewood
Robert, Milroy
Paolo, Pronzato
Uwe, Reinhardt
Daniel, Shasha
Nicholas, Thatcher
Peter, Wilkinson

January 2005

The introduction of recombinant human erythropoietin (rHuEPO) has proven to be a major advance in th...

Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study

Masahiro Tsuboi
Kohji Ezaki
Kensei Tobinai
Yasuo Ohashi
Nagahiro Saijo

January 2008

Objective: The efficacy and safety of weekly administration of epoetin beta (EPO) for chemotherapy-i...

Strategies for the Use of Epoetin Alfa in Breast Cancer Patients

Lucia Del Mastro
Marco Venturini
Guest On A
Lucia Del Mastro
B Marco Venturinib

January 2014

The online version of this article, along with updated information and services, is located o

Comparable Efficacy of Epoetin Alfa for Anemic Cancer Patients Receiving Platinum- and Nonplatinum-Based Chemotherapy: A Retrospective Subanalysis of Two Large, Community-Based Trials

Abstract

Extracted data

Comparable Efficacy of Epoetin Alfa for Anemic Cancer Patients Receiving Platinum- and Nonplatinum-Based Chemotherapy: A Retrospective Subanalysis of Two Large, Community-Based Trials

Abstract

Extracted data

Related items

Related items